SCHEMBL22189188

SCHEMBL22189188

c1ccc(-c2cc3c(c(Nc4cccc5ccccc45)c2-c2ccccc2)Cc2ccccc2-3)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA4 P43681 1/20 0.41
CDC25B P30305 2/20 0.39
ATM Q13315 2/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PDE4B Q07343 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SIGMAR1 Q99720 1/20 0.37
CCR4 P51679 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30302652 1.00 CHRNB2 (0.41) CHRNB2CHRNB4CHRNA3CHRNA4CDC25B
SCHEMBL22157558 0.85 KDR (0.38) ALDH1A1CYP3A4HPGDHSD17B10NPC1
SCHEMBL30302886 0.85 KDR (0.38) ALDH1A1CYP3A4HPGDHSD17B10NPC1
SCHEMBL30021758 0.83 RAPGEF4 (0.43) ALDH1A1CYP3A4HPGDMEN1KMT2A
SCHEMBL30021310 0.82 MAP3K9 (0.39) NPC1RAB9AADORA2AADORA1
SCHEMBL30332599 0.82 WEE1 (0.35) CDC25BALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL30022614 0.82 WEE1 (0.35) CDC25BALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL30021723 0.81 PDGFRB (0.42) CYP3A4TSHRHSD17B10MEN1KMT2A
SCHEMBL22189183 0.81 PDGFRB (0.42) CYP3A4TSHRHSD17B10MEN1KMT2A
SCHEMBL30021673 0.79 NPC1 (0.34) MEN1KMT2ANPC1RAB9ASQOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12590249-B2 Etchant composition SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-03-31 US claimed
US-20220025261-A1 ETCHANT COMPOSITION SOULBRAIN CO., LTD. (KR) 2022-01-27 US claimed
US-12590249-B2 Etchant composition SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-03-31 US disclosed
US-20220025261-A1 ETCHANT COMPOSITION SOULBRAIN CO., LTD. (KR) 2022-01-27 US disclosed
US-11142694-B2 Etchant composition and method of fabricating semiconductor device SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20200216758-A1 ETCHANT COMPOSITION AND METHOD OF FABRICATING SEMICONDUCTOR DEVICE SOULBRAIN CO., LTD. (KR) 2020-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590249-B2 Etchant composition ASIC1, NOS1, CA1 CHRNB2 2114/4885CHRNB4 2468/4885CHRNA3 3206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.